Psychosis Research Today is a free monthly online journal that collates and summarizes the latest research about Psychosis, including details on clinical depression, schizophrenia, bipolar disorder.

Volume 1 (2005), Issue 8 (September)

1. Longitudinal follow-up in acute and transient psychotic disorders and schizophrenia.
   Br J Psychiatry, 187: 286-7. [Abstract] [Full-text]
2. Cognitive performance in presumed obligate carriers for psychosis.
   Br J Psychiatry, 187: 284-5. [Abstract] [Full-text]
3. Social adversity in childhood and the risk of developing psychosis: a national cohort study.
   Am J Psychiatry, 162(9): 1652-7. [Abstract] [Full-text]
4. Cognitive-behavioral therapy in the pre-psychotic phase: an exploratory study.
   Psychiatry Res, 136(2): 251-5. [Abstract] [Full-text]
5. Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder.
   Psychiatry Res, 136(2): 211-21. [Abstract] [Full-text]
6. Psychiatric disorders and their comorbidity in subjects with parasuicide by intentional drug overdose: prevalence and gender differences.
   Psychiatry Res, 136(2): 93-100. [Abstract] [Full-text]
7. Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis.
   Biol Psychiatry, 58(5): 417-23. [Abstract] [Full-text]
8. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.
   Arch Gen Psychiatry, 62(9): 985-94. [Abstract] [Full-text]
9. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review.
   Arch Gen Psychiatry, 62(9): 975-83. [Abstract] [Full-text]
10. Sustained improvement of clinical outcome with risperidone long-acting injectable in psychotic patients previously treated with olanzapine.
    J Psychopharmacol, 19(5): 32-8. [Abstract] [Full-text]
11. Long-acting risperidone in stable patients with schizoaffective disorder.
    J Psychopharmacol, 19(5): 22-31. [Abstract] [Full-text]
12. Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable.
    J Psychopharmacol, 19(5): 5-14. [Abstract] [Full-text]
13. Patients' reports of traumatic or harmful experiences within the psychiatric setting.
    Psychiatr Serv, 56(9): 1123-33. [Abstract] [Full-text]
14. Diagnostic stability four years after a first episode of psychosis.
    Psychiatr Serv, 56(9): 1084-8. [Abstract] [Full-text]
15. Continuity of care and health care costs among persons with severe mental illness.
    Psychiatr Serv, 56(9): 1070-6. [Abstract] [Full-text]
16. Continuity of care and health outcomes among persons with severe mental illness.
    Psychiatr Serv, 56(9): 1061-9. [Abstract] [Full-text]
17. Impact of untreated psychosis on quality of life in patients with first-episode schizophrenia.
    Qual Life Res, 14(8): 1803-11. [Abstract] [Full-text]
18. Dimensional approaches to experimental psychopathology of schizophrenia: shift learning and report of psychotic-like experiences in college students.
    J Behav Ther Exp Psychiatry, 36(4): 300-12. [Abstract] [Full-text]
19. Olanzapine versus risperidone in the treatment of post-psychotic depression in schizophrenic patients.
    Schizophr Res, 78(2): 157-9. [Abstract] [Full-text]
20. Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode.
    Schizophr Res, 78(2): 161-9. [Abstract] [Full-text]
21. Rating the severity and character of transient cocaine-induced delusions and hallucinations with a new instrument, the Scale for Assessment of Positive Symptoms for Cocaine-Induced Psychosis (SAPS-CIP).
    Drug Alcohol Depend, 80(1): 23-33. [Abstract] [Full-text]
22. Developing a service to monitor and improve physical health in people with serious mental illness.
    J Psychiatr Ment Health Nurs, 12(5): 614-9. [Abstract] [Full-text]
23. Developing services for the carers of young adults with early-onset psychosis--listening to their experiences and needs.
    J Psychiatr Ment Health Nurs, 12(5): 589-97. [Abstract] [Full-text]
24. A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness.
    BMJ, 331(7517): 602. [Abstract] [Full-text]
25. A controlled trial of cognitively oriented psychotherapy for early psychosis (COPE) with four-year follow-up readmission data.
    Psychol Med, 35(9): 1295-306. [Abstract] [Full-text]
26. Patterns and predictors of substance use disorders and daily tobacco use in first-episode psychosis.
    Aust N Z J Psychiatry, 39(10): 892-8. [Abstract] [Full-text]
27. Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study.
    Neuropsychopharmacology, 30(10): 1923-31. [Abstract] [Full-text]
28. Development and evaluation of the Parkinson Psychosis Questionnaire A screening-instrument for the early diagnosis of drug-induced psychosis in Parkinson's disease.
    J Neurol, 252(9): 1060-6. [Abstract] [Full-text]
29. Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state.
    Eur Psychiatry, 20(5): 372-8. [Abstract] [Full-text]
30. Survey of depot antipsychotic prescribing in southern Adelaide.
    Australas Psychiatry, 13(3): 253-7. [Abstract] [Full-text]
31. Development of clinical guidelines for the pharmacological management of behavioural disturbance and aggression in people with psychosis.
    Australas Psychiatry, 13(3): 247-52. [Abstract] [Full-text]
32. Psychosis or faith? Clinicians' assessment of religious beliefs.
    J Consult Clin Psychol, 73(4): 610-6. [Abstract] [Full-text]
33. The development and implementation of an educational intervention on first episode psychosis for primary care.
    Med Educ, 39(10): 1006-14. [Abstract] [Full-text]
34. Functional polymorphism of the NQO2 gene is associated with methamphetamine psychosis.
    Addict Biol, 10(2): 145-8. [Abstract] [Full-text]
35. Use of combinations of antipsychotics: McLean Hospital inpatients, 2002.
    Hum Psychopharmacol, 20(7): 485-92. [Abstract] [Full-text]
36. Community care for people with psychosis: outcomes and needs for care.
    Int Rev Psychiatry, 17(2): 89-95. [Abstract] [Full-text]
37. Insight in people with psychosis: the influence of culture.
    Int Rev Psychiatry, 17(2): 83-7. [Abstract] [Full-text]
38. Shadows of culture in psychosis in south India: a methodological exploration and illustration.
    Int Rev Psychiatry, 17(2): 75-81. [Abstract] [Full-text]
39. Intensive case management for severe psychotic illness: is there a general benefit for patients with complex needs? A secondary analysis of the UK700 trial data.
    Soc Psychiatry Psychiatr Epidemiol, 40(9): 718-24. [Abstract] [Full-text]
40. Background factors as determinants of satisfaction with care among first-episode psychosis patients.
    Soc Psychiatry Psychiatr Epidemiol, 40(9): 749-54. [Abstract] [Full-text]

© 2005-2008 Psychosis Research Today. All Rights Reserved.